Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Pathology, Research and Practice

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 10982019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of sodium bis(oxalato)oxovanadate(IV) on phospholipids in liver Golgi fractions from control and streptozotocin-diabetic rats.

  2000cited by this paper
• Influence of bis(maltolato)oxovanadium(IV) on activity of galactosyltransferase (GalT) and morphology of rat liver Golgi apparatus in control and streptozotocin diabetes.

  1998cited by this paper
• Vanadium and diabetes

  1998cited by this paper
• Vanadyl Sulfate Does Not Enhance Insulin Action in Patients With Type 1 Diabetes

  1998cited by this paper
• Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands.

  1997cited by this paper
• Influence of LEPK on biochemical activity and morphology in situ of liver Golgi apparatus from control and streptozotocin-diabetic rats.

  1997cited by this paper
• Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats.

  1997cited by this paper
• Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation

  1997cited by this paper
• Vanadium compounds biological actions and potential as pharmacological agents.

  1997cited by this paper
• Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.

  1997cited by this paper
• Insulin-like effects on liver Golgi membrane preparations of bis(oxalato)oxovanadate(IV) complex ion, a new vanadate compound.

  1997cited by this paper
• Partial preservation of pancreatic beta-cells by vanadium: evidence for long-term amelioration of diabetes.

  1997cited by this paper
• Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Formation of nascent secretory vesicles from the trans-Golgi network of endocrine cells is inhibited by tyrosine kinase and phosphatase inhibitors

  1996cited by this paper
• Oral Vanadyl Sulfate Improves Insulin Sensitivity in NIDDM but Not in Obese Nondiabetic Subjects

  1996cited by this paper
• Increased potency of vanadium using organic ligands

  1995cited by this paper
• Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies.

  1995cited by this paper
• Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.

  1995cited by this paper
• Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents

  1995cited by this paper
• Toxicology of vanadium compounds in diabetic rats: The action of chelating agents on vanadium accumulation

  1995cited by this paper
• Oral Vanadium and Lowering of Blood Glucose

  1994cited by this paper
• Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).

  1993cited by this paper
• Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).

  1993cited by this paper
• Induction of neoplastic progression in Syrian hamster embryo cells treated with protein phosphatase inhibitors.

  1993cited by this paper
• Cytogenetic damage induced in human lymphocytes by four vanadium compounds and micronucleus analysis by fluorescence in situ hybridization with a centromeric probe.

  1993cited by this paper
• Role of the golgi apparatus in cellular pathology

  1991cited by this paper
• Cytoprotective effect of 16,16' dimethyl prostaglandin E2 (dm PGE2) on streptozotocin-induced biochemical alterations of Golgi-rich membrane fraction in comparison with morphology of rat liver Golgi apparatus in situ.

  1986cited by this paper
• The streptozotocin-prostaglandin interaction in Golgi apparatus of rat liver.

  1986cited by this paper
• Influence of insulin on galactosyl transferase activity and morphology of the liver Golgi apparatus in control and streptozotocin-diabetic rats.

  1981cited by this paper
• Morphology of the Golgi apparatus in streptozotocin-diabetic rat liver.

  1980cited by this paper
• Chromosome movement in lysed mitotic cells is inhibited by vanadate

  1978cited by this paper
• The activity of Golgi-membrane galactosyltransferase in the liver of streptozotocin-diabetic rats.

  1977cited by this paper
• Isolation and characterization of Golgi apparatus and membranes from rat liver.

  1974cited by this paper
• A SIMPLIFIED LEAD CITRATE STAIN FOR USE IN ELECTRON MICROSCOPY

  1965cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Comparison of bipyridyl, maltol and kojic acid action as organic vanadium ligands on activity of galactosyltransferase (EC 2.4.1.38), some physiological parameters and ultrastructure of Golgi complexes in rat hepatocytes.

  2007cites this paper
• Sodium orthovanadate exerts influence on liver Golgi complexes from control and streptozotocin-diabetic rats.

  2005cites this paper
• Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes.

  2004cites this paper
• Trigonella foenum graecum seed powder protects against histopathological abnormalities in tissues of diabetic rats

  2004cites this paper
• Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.

  2004cites this paper
• Streptozotocin-induced Alterations in Rat Liver Golgi Complexes are Ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] Activity

  2004cites this paper
• The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.

  2002cites this paper
• The Influence of a New Vanadium Compound, Bis(2,2’-bipyridine)oxovanadium(IV) Sulphate on Liver Golgi Complexes from Control and Streptozotocin-Diabetic Rats

  2002cites this paper
• Effect of oxovanadium(IV) complexes on nondiabetic and streptozotocin‐diabetic rats

  2001cites this paper